We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Korean Market Trial

21 May 2009 07:00

RNS Number : 6262S
Phorm Inc
21 May 2009
 



Phorm, Inc. ('Phorm' or 'the Company')

 

Korean Market Trial

 

Further to the announcement on 30 March 2009, Phorm (AIM: PHRM and PHRX), the interest-based advertising technology company, is pleased to confirm that it yesterday commenced its market trial with leading Korean internet service provider (ISP) KT.

KT customers opting into the trial will not only benefit from existing features such as enhanced user privacy and more relevant advertising, but will also be invited to experience an innovative new consumer proposition, which will be demonstrated by Phorm at a media and publisher event in the UK on June 2009.

TJ Kang, Executive Vice President of KT said: "KT is pleased to be working with Phorm in Korea to introduce this groundbreaking technology."

Kent Ertugrul, CEO of Phorm, said: "KT is a leader in one of the most advanced broadband markets in the world. This trial represents a substantial opportunity for Phorm and underlines the international potential of our technology. In the coming weeks we will be working very closely with KT to ensure the smooth running of the trial and we look forward to providing an update to the market once it is concluded. I am particularly excited to be able to introduce the revolutionary centerpiece of our consumer proposition in London on 3 June 2009."

Enquiries:

Phorm, Inc

Benjamin Usher

+44 20 7297 2521

Sarah Simon

+44 20 7297 2433

 

Phorm Korea

Daniel Park

+82 10 2000 1320

Citigate Dewe Rogerson

+44 20 7638 9571 

Justin Griffiths 

Simon Rigby

 

Canaccord Adams Limited

+44 20 7050 6500 

(Nominated Adviser)

Mark Williams

Andrew Chubb

Notes to Editors:

According to the Organisation for Economic Co-operation and Development (OECD), Korea has approximately 15 million broadband customers, making it the sixth largest broadband market in the world. Furthermore, with household penetration of around 90%, Korea has higher broadband take-up than markets including the UK, the US and Japan. Zenith Optimedia estimates that Korea's online advertising market was worth $1.6 billion (15.5% of total domestic marketing spend) in 2008, making it the seventh largest market globally. KT is the leading ISP in Korea with an estimated market share of 44%.

About Phorm: 

Phorm is an innovative advertising technology company specialising in interest-based advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in New York and London.

 

The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

 

For more information, please visit: www.phorm.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPUUPAAUPBUAG
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.